Free Shipping Within the US
Money Back Guarantee


Dale blog imageAuthor: Dale Hewett
Table of Contents (Scrollable)


As the name implies, CBC is similar to other natural cannabinoids like cannabidiol (CBD), cannabinol (CBN), tetrahydrocannabivarin (THCV), and tetrahydrocannabinol (THC).

CBC by itself does not produce any psychoactive effects, although some studies show that CBC can intensify the effects THC has on the body.

CBC is reported to have been simultaneously discovered by two groups of scientists: Gaoni and Mechoulam, as well as Claussen, Von Spulak, and Korte in 1966. The two groups of scientists isolated the compound by using either a hexane or florisil extraction method from hashish or benzene percolation of hemp[1].

After its discovery, studies in 1970 reported that CBC was the second most abundant cannabinoid in the cannabis plant. This is not currently the case today as many years of cross-breeding have created plants with higher CBD and THC contents.

Related: CBD vs CBN

These same studies used only cannabis plants originating from the tropics. Due to their location, these cannabis plants had a higher concentration of CBC and had little to no resemblance when compared with modern hybrids[2].

CBC originates as CBCA, and is then turned into CBC via the process of decarboxylation, which involves heating the substance at a high temperature.


Although CBC is a non-psychoactive member of the cannabinoid family, it may alter the psychoactivity of THC. CBC does not have a high binding affinity for either the CB1 or CB2 receptors, but it does act on the TRPV1 and TRPA1 receptors.

Related: THC vs CBD

TRVP1 is known as the vanilloid receptor 1 or capsaicin receptor. It is responsible for detecting and regulating body temperature. It also plays an active role in pain and heat sensation (nociception).

CBC interacts with the TRVP receptors to break down endocannabinoids like anandamide 2-Arachidonoylglycerol (2-AG). This activity has shown great promise in the overall therapeutic benefits of CBC.


1. Anti-inflammatory properties

The anti-inflammatory properties of CBC are more profound when combined with THC. CBC is effective at reducing intestinal inflammation and providing relief to patients with IBS. CBC also helps to regulate inhibitory roles on inflammation-induced hypermotility in mice.[3] Research performed in 2010 suggests that CBC weakly binds to CB2 receptors resulting in reduced inflammation throughout the body.

2. Antidepressant properties

CBC possesses more potent antidepressant activity than CBD. This activity is made stronger by the presence of other cannabinoids which produce a synergistic effect. In one study, it was discovered that CBC reduced the rate of depression in mice at a dose of 20mg/kg as compared to a 200 mg/kg dose of CBD needed to achieve the same result. [4] In another study CBC was found to be the primary contributor to the overall mood-elevating properties of cannabis.

3. Pain Blocking properties

Many people use CBC for pain relief from chronic injuries. CBC has been found to provide pain relief from nerve damage. CBC acts in synergy with THC to produce better pain-relieving properties than when used alone.[5]

CBC is also effective at reducing pain from osteoarthritis in a different way than typical NSAID (non-steroidal anti-inflammatory) medications.

4. Neuroprotective Effects

A 2013 study on mice shows that CBC can increase progenitor stem cell survival rate, thereby increasing neurogenesis.

5. Antibacterial activity

Research conducted as early as 1980 reports that CBC possesses excellent antimicrobial activity against bacterial and fungal species. Antibacterial activity was strongest against gram-positive, gram-negative, and acid-fast bacteria, while anti-fungal activity was mild to moderate against yeast-like fungal species.

6. Skincare Benefits

CBC plays an active role in the reduction of sebum production by the sebaceous gland. This is very important in the treatment of skin conditions like acne and may provide an alternative to stronger medications like Isotretinoin (Accutane). More research is needed but initial studies look promising.

7. Migraine Prevention

A new theory being proposed is that people with chronic migraines may have a deficiency in natural endocannabinoids by up to 50%. CBC helps to block anandamide (a natural cannabinoid) from breaking down the body, resulting in higher natural endocannabinoid levels.

Oxidative stress in the brain is thought to be one major trigger of migraines. Progenitor cells in the brain produce astrocytes which reduce oxidative damage. Since CBC helps to increase progenitor cell survival rate, it helps prevent migraines by extension.

8. Anti-Cancer Effects

According to a study performed in 2006, CBC is the second most effective cannabinoid at preventing the growth of tumors. In another study, CBC was shown to induce cell apoptosis, inhibit cell migration, and affect F-actin integrity.

We want to be clear that we are not stating CBC can cure cancer, however, it does appear to be effective at halting tumor growth in initial studies.


  1. CBC is the third most popular cannabinoid in the cannabis plant after THC and CBD.
  2. Since CBC is non-psychoactive, it is often absent from controlled substance lists and is legal in many different parts of the world.
  3. CBC does not have a strong affinity for the CB1 or CB2 receptors. It exerts its effects on the body by indirectly activating the endocannabinoid system and through other receptors such as the TRVP receptors.


[2] Holley, J. H., Hadley, K. W., & Turner, C. E. (1975). Constituents of Cannabis sativa L. XI: Cannabidiol and Cannabichromene in Samples of Known Geographical Origin. Journal of Pharmaceutical Sciences, 64(5), 892–895.

[3]  Izzo, A. A., Capasso, R., Aviello, G., Borrelli, F., Romano, B., Piscitelli, F., … Di Marzo, V. (2012). Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice. British Journal of Pharmacology, 166(4), 1444–1460. doi:10.1111/j.1476-5381.2012.01879.x

[4] El-Alfy, A. T., Ivey, K., Robinson, K., Ahmed, S., Radwan, M., Slade, D., Khan, I., ElSohly, M., & Ross, S. (2010). Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. Pharmacology, biochemistry, and behavior95(4), 434–442.

[5] DeLong, G. T., Wolf, C. E., Poklis, A., & Lichtman, A. H. (2010). Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene, and its modulation by Δ(9)-tetrahydrocannabinol. Drug and alcohol dependence112(1-2), 126–133.


blog BG
Table of Contents

Search our website for more information on CBD:

Related Cannabinoids

Commitment to Trusted Information on CBD

When it comes to understanding both the science and benefits of cannabidiol (CBD), it is extremely important that you can trust the source of your information. This is exactly why our team at New Phase Blends includes experts in the field of cannabinoid research and development, including frequent correspondence with certified medical professionals and PhDs in relevant fields via studies, research, and additional peer reviewed pieces of information. All information published is reviewed and checked for accuracy. We pride ourselves on staying up-to-date with the latest scientific research and clinical studies related to not only CBD, but also its effects on the human body.

Our website also includes an About Us page, where you can learn more about our team, mission, and commitment to providing accurate, reliable information about CBD. Users can access this from the header menu at the top of the screen. Additionally, all of our products are third-party lab tested for quality and purity, and we make the results of these tests easily accessible to our customers.

User Experience Strengthened Through The Use of AI Content

Some articles you read may contain content created by the use of AI tools. This content is always edited by a human. We fact check any AI content, and ensure the information produced is accurate, up to date, and relevant to the article it may be contained in. All content is verified against peer reviewed data on CBD written by PhD’s and respective experts in their field of medical science.

Our goal in using AI content is to increase the user experience by increasing content production, and quality. This results in more information becoming available to the reader more frequently.

About the Author - CBD Expert Dale Hewett

Dale Hewett Author
Dale Hewett

Dale Hewett is the owner and founder of New Phase Blends. He discovered his passion for CBD use after suffering from injuries sustained while on Active Duty in the US Army. His number one priority is introducing the same CBD products that he himself uses for relief to others who can benefit from them.

Dale holds a Master Degree of Science, and is the inventor of the popular, CBD-based sleep aid known as ‘Sleep.’ He’s given multiple lectures on CBD to institutions such as Cornell’s MBA student program, and Wharton’s School of Business.

la wire logo
yahoo finance greyscale
forbes logo
Markets Insider Logo
chicago journal logo greyscale